Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Covington
US Department of Justice
Fish and Richardson
Deloitte
Moodys
Argus Health
Teva
Citi

Generated: April 21, 2018

DrugPatentWatch Database Preview

TERBUTALINE SULFATE Drug Profile

« Back to Dashboard

Which patents cover Terbutaline Sulfate, and what generic alternatives are available?

Terbutaline Sulfate is a drug marketed by Akorn, Athenex Inc, Fresenius Kabi Usa, Hikma Farmaceutica, Teva Pharms Usa, United Biomedcl, Impax Labs, and Lannett. and is included in eight NDAs.

The generic ingredient in TERBUTALINE SULFATE is terbutaline sulfate. There are seven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
Summary for TERBUTALINE SULFATE
US Patents:0
Applicants:8
NDAs:8
Suppliers / Packagers: 13
Bulk Api Vendors: 82
Clinical Trials: 687
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TERBUTALINE SULFATE at DailyMed
Drug patent expirations by year for TERBUTALINE SULFATE
Medical Subject Heading (MeSH) Categories for TERBUTALINE SULFATE
Adrenergic beta-2 Receptor Agonists
Bronchodilator Agents
Sympathomimetics
Tocolytic Agents

US Patents and Regulatory Information for TERBUTALINE SULFATE

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078151-001 Jan 7, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 075877-001 Jun 26, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hikma Farmaceutica TERBUTALINE SULFATE terbutaline sulfate INJECTABLE;INJECTION 078630-001 May 20, 2009 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Impax Labs TERBUTALINE SULFATE terbutaline sulfate TABLET;ORAL 075877-002 Jun 26, 2001 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cipla
Citi
US Army
Accenture
Cerilliant
Daiichi Sankyo
McKinsey
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
DrugPatentWatch reviews  
Links

Follow DrugPatentWatch: